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Lowe syndrome is a rare X-linked congenital disease that presents
with congenital cataracts and glaucoma, as well as renal and cerebral
dysfunction. OCRL, an inositol polyphosphate 5-phosphatase, is mu-
tated in Lowe syndrome. We previously showed that OCRL is in-
volved in vesicular trafficking to the primary cilium. Primary cilia
are sensory organelles on the surface of eukaryotic cells that mediate
mechanotransduction in the kidney, brain, and bone. However, their
potential role in the trabecular meshwork (TM) in the eye, which
regulates intraocular pressure, is unknown. Here, we show that
TM cells, which are defective in glaucoma, have primary cilia that
are critical for response to pressure changes. Primary cilia in TM cells
shorten in response to fluid flow and elevated hydrostatic pressure,
and promote increased transcription of TNF-α, TGF-β, and GLI1 genes.
Furthermore, OCRL is found to be required for primary cilia to
respond to pressure stimulation. The interaction of OCRL with tran-
sient receptor potential vanilloid 4 (TRPV4), a ciliary mechanosensory
channel, suggests that OCRL may act through regulation of this chan-
nel. A novel disease-causing OCRL allele prevents TRPV4-mediated
calcium signaling. In addition, TRPV4 agonist GSK 1016790A treat-
ment reduced intraocular pressure in mice; TRPV4 knockout animals
exhibited elevated intraocular pressure and shortened cilia. Thus,
mechanotransduction by primary cilia in TM cells is implicated in
how the eye senses pressure changes and highlights OCRL and TRPV4
as attractive therapeutic targets for the treatment of glaucoma. Impli-
cations of OCRL and TRPV4 in primary cilia function may also shed
light on mechanosensation in other organ systems.
Oculocerebrorenal syndrome of Lowe is a rare X-linkedrecessive disorder that presents in males with bilateral
cataracts and glaucoma, as well as renal failure, muscular hy-
potonia, and mental retardation (1). The defective gene, OCRL,
encodes an inositol polyphosphate 5-phosphatase; its sub-
strates include phosphatidylinositol-4,5-bisphosphate [PI(4,5)P2] and
phosphatidylinositol-3,4,5-trisphosphate [PI(3,4,5)P3] (2). De-
creased 5-phosphatase activity is demonstrated in fibroblasts
from Lowe patients as well as a two- to threefold elevated ratio
of PI(4,5)P2: PI(4)P (3). We and others have recently identified
a novel link between OCRL and primary cilia (4–7).
The primary cilium is an evolutionarily conserved subcellular
structure that protrudes from many postmitotic eukaryotic cells (8,
9). In response to changes in the extracellular environment, pri-
mary cilia coordinate signaling cascades that control cell differ-
entiation, growth, and function (10). A highly specialized extension
of the plasma membrane, the ciliary membrane is enriched with
many signaling proteins, including transient receptor potential
(TRP) channels (11). Upon extracellular stimulation, TRP chan-
nels initiate signal transduction cascades by inducing Ca2+ flow.
Phosphoinositides within the ciliary membrane are essential sec-
ond messengers for ciliary function, potentially through modula-
tion of the activities of TRP channels (12, 13). Genetic defects in
cilia formation or maintenance underlie a wide array of human
diseases, including retinitis pigmentosa, renal cysts, polydactyly,
and developmental delays, which are collectively called ciliopathies
(14–17).
Although some forms of ciliopathies present with disease states
of fluid dysregulation, including hydrocephalus (18, 19), it is un-
known if elevated eye pressure may be caused by ciliary disease.
Glaucoma is an optic neuropathy associated with elevated in-
traocular pressure (IOP) and is a leading cause of irreversible
blindness in the world (20, 21). Consistent with the central role of
increased pressure in the pathology of glaucoma, the only proven
treatment for glaucoma is to lower eye pressure (22). Trabecular
meshwork (TM) cells are responsible for the drainage of the
majority of aqueous fluid (23), and dysfunction of the trabecular
outflow leads to elevated IOP. In susceptible individuals, this
results in the death of retinal ganglion cells, causing irreversible
vision loss (24). However, the molecular events whereby elevated
pressure results in aberrant mechanosensory signaling that leads
to visual loss are poorly understood. Here we provide evidence
that primary cilia are the pressure-sensing organelles in the TM;
mutation of OCRL in TM cilia prevents proper functioning of the
TRP vanilloid 4 (TRPV4) channel that in turn diminishes TM
function and causes increased IOP.
Results
OCRL Mutation in a Patient with Congenital Glaucoma. We have
identified an 8-y-old male with Lowe syndrome who was born
with bilateral congenital glaucoma and cataracts. Less than 12 h
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postpartum, the child was noted to have corneal edema and el-
evated pressures in both eyes and increased optic nerve cupping
(Fig. 1A). The patient subsequently underwent multiple surgeries
for glaucoma, including trabeculectomy and trabeculotomy, with
poorly controlled disease (Fig. S1A). DNA sequencing revealed
a novel missense mutation in the region encoding the 5-phos-
phatase domain of the OCRL gene (c.1661 A > C; p.D499A)
(Fig. S1B). Based on its position in the OCRL structure, this
aspartic acid residue is predicted to affect the 5-phosphatase
activity of OCRL (Fig. S1C). Consistent with OCRL functioning
in the cilia of retinal pigmented epithelial cells (4, 6, 7), the cilia
in keratinocytes derived from this patient were defective. Fol-
lowing serum-starvation, these cells exhibited shortened cilia
compared with keratinocytes from a healthy individual (Fig. 1 B
and C). Upon reintroduction of wild-type OCRL, the shortened
cilia phenotype was partially rescued (Fig. 1 B and C). To further
assess the role of OCRL in cilia, the localization of OCRL was
visualized in human trabecular meshwork (HTM) cells following
serum-starvation by immunofluorescence. OCRL is concen-
trated in the axoneme or the membrane of the primary cilium
(Fig. 1D). The OCRL mutant cDNA (OCRL D499A) was then
expressed in HTM cells, which resulted in cilia from these cells
forming significantly shorter structures than control cells upon
serum-starvation (Fig. 1D and Fig. S1 D, E, and H). Additionally,
OCRL knockdown HTM cells exhibited shortened cilia, which
could be rescued by wild-type OCRL (Fig. S1 F and G). Taken
together, these data support OCRL function in cilia formation
in TM cells, which when defective resulted in glaucoma de-
velopment in a human patient.
Primary Cilia Are Present in the TM of the Eye. In aqueous humor
regulation, the TM is generally accepted as the anatomical site of
greatest resistance to outflow (23) (Fig. 2A). Although cilia-like
structures have been observed in the pericanalicular region of the
eye, primary cilia have not been characterized (25–27). Based on
the results from the congenital glaucoma patient with Lowe syn-
drome, we sought to visualize cilia in isolated TM tissue from the
anterior segment of human eyes by immunofluorescence and
electron microscopy. The ciliary membrane covers a microtubule-
based axoneme and is anchored by a basal body (10). Primary cilia
were detected in TM tissues by immunostaining for acetylated
α-tubulin or Arl13b, a small GTPase localized in the cilia, whereas
the basal body was detected by staining for γ-tubulin. In cadaveric
normal human eyes, immunofluorescence staining revealed nu-
merous cilia-like structures in the uveoscleral region of the TM
(Fig. 2B). Similar staining of cilia in TM tissues that were removed
en face immediately following trabeculectomy from the eyes of
glaucoma patients also detected primary cilia (Fig. 2C). Specificity
for TM was verified by immunostaining of myocilin, a TM-
enriched protein (Fig. S2A) (28). Similarly, primary cilia staining
was noted in the TM of bovine, porcine, and murine eyes (Fig. S2
B–E). Electron microscopy revealed the characteristic “9+0” ar-
rangement in the primary cilia of the TM cells (Fig. 2D and Fig.
S2F). Thus, primary cilia are present in the TM cells of multiple
mammalian species.
Serum-starvation is a well-described method for the induction
of primary cilia (29). The formation of cilia was therefore mea-
sured in cultured HTM cells at different times following serum-
starvation, by detection of Arl13b, IFT88, IFT43, IFT57 (intra-
flagellar transport proteins), adenylate cyclase III (a cilia marker),
and γ-tubulin by immunofluorescence (Fig. 2E). The average
lengths of cilia increased following serum deprivation. At 24 h
the cilia lengths were 2.2 ± 0.7 μm; at 48 h, 4.3 ± 0.6 μm; and
72 h, 5.6 ± 0.4 μm (Fig. S3). This finding confirms the presence
of primary cilia in TM cells.
Pressure-Dependent Cilia Shortening and Gene Transcription. Be-
cause primary cilia mediate pressure sensation in the kidneys,
brain, and bone (30–32), we examined the effect of pressure
changes on cilia length in TM cells. In acute angle-closure glau-
coma, intraocular pressure frequently can rise to 50 mmHg. HTM
cells cultured in a pressure chamber were subjected to atmo-
spheric (0 mmHg) or 50-mmHg hydrostatic pressure for 3 h. After
fixation, cilia were imaged by immunostaining with acetylated
α-tubulin (Fig. 3A). Average cilia lengths were 5.3 ± 0.2 μm in the
normal pressure group and 3.9 ± 0.2 μm after 1 h of treatment
(Fig. 3B). Overall, ciliary length in TM cells was reduced by
pressure in a time-dependent fashion (Fig. 3C). Changes in ciliary
length were both time- and dose-dependent processes.
TNF-α and TGF-β are both highly abundant in the aqueous
humor of patients with both acute and chronic forms of glaucoma
(33–35). To determine whether the expression of TNF-α was
up-regulated in response to pressure, its transcript levels were
measured by quantitative RT-PCR (qRT-PCR) under different
pressures. Following 1 h of application of 50-mmHg pressure,
a robust elevation of TNF-α transcription was observed (Fig. 3D).
The lack of changes in IL-33 transcript indicates that the effects on
TNF-α are specific (Fig. S4A). Further, application of 50-mmHg
Fig. 1. OCRL mutation in a Lowe syndrome patient with congenital glau-
coma. (A) Optic nerve photos of the glaucoma patient. Photograph dem-
onstrating glaucomatous optic nerve cupping in affected patient (cupping
represented with dashed line). (B and C) Ciliary defect in a Lowe syndrome
patient. After cilia induction by serum-starvation for 48 h, normal control
(NHKC), Lowe syndrome patient (Lowe), and WT-GFP-OCRL transduced pa-
tient keratinocytes (Lowe +WT) were measured for ciliary length by staining
with antiacetylated α-tubulin (red) and γ-tubulin (green) antibodies. Represen-
tative figure is shown in C. Average of three independent experiments, n = 50
cilia. Error bars represent SD. ANOVA, P < 0.001. (Scale bar, 10 μm.) (D) Primary
cilia in HTM cells transfected with wild-type and mutant OCRL. HTM cells
transfected with GFP-OCRL-WT or GFP-OCRL-D499A, followed by serum-
starvation for 48 h, were then stained with acetylated α-tubulin. (Scale bar,
5 μm.)
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pressure markedly elevated the transcript levels of TNF-α and
TGF-β1, and had a modest effect on GLI1, a factor in the
Sonic Hedgehog pathway (Fig. 3D). Cilia were ablated by shRNA
knockdown of RAB8 (Fig. 3D and Fig. S4B), which inhibits cilio-
genesis (36). Cells with reduced expression of Rab8 showed a re-
duction of gene transcription of TNF-α and TGF-β1 in response to
pressure. In a complementary approach, the dependence of these
effects on functional cilia was then determined by testing their
sensitivity to chlorohydrate, which effectively removes cilia (30). The
treatment of ciliated cells with chlorohydrate reduced the tran-
scriptional activation in response to pressure (Fig. S4D). Taken
together, these experiments strongly suggest that enhanced tran-
scription of TNF-α and TGF-β1 by pressure occurs via a cilia-
dependent process.
To further characterize the distribution of ciliary proteins
under elevated pressure conditions, we examined intraflagellar
transport (IFT) proteins. We examined the distribution of pro-
teins involved in both anterograde (IFT57, IFT88) and retro-
grade (IFT20, IF43, IFT144) ciliary trafficking. Only IFT88 was
found to have a markedly altered distribution under increased
pressure conditions. In control HTM cells, IFT88 distributed to
the base as well as to the tip of the axoneme; in HTM cells
treated with pressure, IFT88 accumulated at the base of the cilia
with a marked decrease at the ciliary tip (Fig. 3E and Fig. S4E).
Thus, elevated pressure in cells may alter IFT distribution with
a resultant change in ciliary protein trafficking.
Given the potential role of OCRL in pressure sensing, we
assessed the requirement for OCRL for the activation of tran-
scription in HTM cells in response to pressure. The expression of
OCRL was silenced in HTM cells with lentiviral shRNA. Cilio-
genesis was then induced by serum-starvation, followed by pres-
sure stimulation (Fig. S4 C and F). Cells with reduced OCRL
exhibited a significant loss of pressure-dependent TGF-β, TNF-α,
and GLI1 transcriptional activity, which was restored by reex-
pression of wild-type OCRL (Fig. S4F).
In a separate approach, pressure-dependent transcription of
TGF-β was assessed in primary fibroblasts obtained from wild-
type control (NHF558 cells) versus primary fibroblasts from two
previously described Lowe syndrome patients with nonfunctional
OCRL protein (6) (Fig. S4G). The levels of TGF-β transcript
modestly increased following elevated pressure in mutant cells,
whereas cells expressing wild-type OCRL showed significant in-
creased elevation of TGF-β in response to pressure. This result
further supports that pressure activates the transcription of TNF-α
Fig. 2. Primary cilia are conserved in mammalian TM. (A) Schematic of
aqueous humor outflow in the eye. Aqueous humor is generated in the
ciliary body, and drains out of the trabecular meshwork. (B and C) Primary
cilia in normal and glaucomatous human TM. TM removed from human
donor eyes (B) and surgical TM specimens during glaucoma surgery (C) were
immunostained with anti-Arl13b (red), acetylated α-tubulin (AcTub, red),
γ-tubulin (γ-Tub, green), and DAPI (blue). (Scale bar, 5 μm.) (D) Electron
micrograph of a primary cilium in HTM in a glaucomatous eye. TM specimen
removed during glaucoma surgery was imaged by transmission electron
microscopy. (Scale bar, 500 nm.) (E) Characterization of primary cilia in cul-
tured HTM cells. Serum-starved to induce ciliogenesis, HTM cells were
immunostained with antiacetylated α-tubulin (AcTub, red), IFT88 (green),
IFT43 (green), IFT57 (green), Adenylate cyclase III (green), pericentrin (green),
and γ-tubulin (γ-Tub, green) antibodies. DAPI in blue. (Scale bar, 5 μm.)
Fig. 3. Cilia shortening in response to pressure. (A and B) Elevated pressure
resulted in ciliary shortening in HTM cells. HTM cells were serum-starved for
48 h, cultured in atmospheric (0 mmHg) or 50-mmHg pressure for 60 min,
followed by immunostaining for acetylated α-tubulin. Cilia shown in Inset;
cilia length was measured and shown in B. Error bars represent SD. n > 50
cilia, three independent experiments, paired t test. *P < 0.05. (Scale bar
in A, 5 μm.) (C) HTM cells were serum-starved for 48 h, cultured in 50-mmHg
pressure, for 0, 1, or 3 h, followed by immunostaining for acetylated α-tu-
bulin. Cilia length was measured and shown. Error bars represent SD. n > 50
cilia, three independent experiments unpaired t test, *P < 0.01, **P < 0.001.
(D) Pressure-mediated transcriptional activation requires primary cilia. Cilia
formation in HTM cells (control and stable Rab8 knockdown) were induced
by serum-starvation for 48 h followed by treatment with or without
50-mmHg pressure for 3 h. Levels of mRNA of TNF-α, GLI1, and TGF-β were
measured. Three independent experiments with error bars represent SD.
*P < 0.001; ns, not significant. (E) Altered distribution of IFT88 with elevated
pressure. HTM cells were serum-starved to induce ciliogenesis, followed by
treatment with or without elevated pressure (50 mmHg). Representative
images of immunostaining with antibodies for IFT88 (green), acetylated
α-tubulin (red), and DAPI (blue), showing the loss of IFT88 in the distal tip of
cilia under elevated pressure conditions. (Scale bar, 10 μm.)











and TGF-β in a manner that requires cilia, which in turn are
dependent on functional OCRL.
TRPV4 and OCRL Interact and Localize to the Cilia. Because we found
cilia of human TM cells to respond to pressure changes, and
OCRL is known to transport membrane bound proteins, we
hypothesized that it may interact with a mechanosensory channel
within the cilia. TRPV4 is a mechanosensitive calcium-perme-
able cation channel that localizes to cilia, where it functions in
osmotic regulation (32, 37–39). TRPV4 dysregulation has been
implicated in diseases with fluid overload, such as hydrocephalus
and heart failure (32, 40). Therefore, we investigated if OCRL
and TRPV4 may play a role in TM cilia. First we showed that
OCRL and TRPV4 interacted by coimmunoprecipitation assays.
Coexpression of tagged GFP-OCRL and FLAG-TRPV4 fol-
lowed by incubation with anti-GFP-Trap_A beads resulted in
isolation of FLAG-tagged TRPV4 proteins (Fig. 4A and Fig.
S5A). Conversely, reverse immunoprecipitation with anti-FLAG
beads for TRPV4 was able to isolate OCRL-GFP (Fig. 4B).
Second, we showed that in HTM cells TRPV4 is expressed and
localized in the primary cilia, as indicated by staining for acety-
lated α-tubulin (Fig. 4C). To determine if the OCRL D499A
mutant has an effect on the localization of TRPV4, the distri-
bution of TRPV4 in the presence of wild-type OCRL or D499A
mutant was determined. In HTM cells expressing both TRPV4
and OCRL, ciliary distribution of TRPV4 in OCRL D499A
mutant cells was diminished (Fig. 4D). We assessed the function
of the OCRL D499A mutant in vitro and found the enzymatic
activity of PI(4,5)P2 5-phosphatase was decreased twofold com-
pared with the wild-type enzyme (Fig. S5B). However, the sta-
bility of the protein was not significantly affected (Fig. S5C).
Taking these data together, we show that OCRL interacts with
TRPV4 calcium channel and both proteins localize within the
primary cilia.
OCRL and TRPV4 Regulate Calcium Flux in Human TM Cells and IOP in
Mice. Based on the interaction and colocalization of OCRL and
TRPV4, we assayed for the mechanosensory function of TRPV4
in HTM cells in response to flow. We showed that TRPV4 ex-
pression is similar in Lowe patients and normal HTM cells (Fig.
S6 A and B). In Fura-2–loaded HTM or Lowe cells, Ca2+ flux
was induced by laminar flow gradient (16 μL/s) over the cell
surface (Fig. 5A) (32). Calcium flux was measured by F340/380
ratio in HTM cells poststimulation with the TRPV4 agonist
GSK1016790A. Using this technique, we analyzed the stimula-
tion of TRPV4 under various conditions. First we evaluated
whether HTM cells treated with or without pressure responded
differently to the TRPV4 agonist. In ciliated HTM cells treated
with 50-mmHg hydrostatic pressure, we observed a significant
decrease in TRPV4-induced calcium flux (Fig. 5B). Second, us-
ing OCRL siRNA or scrambled control siRNA-treated HTM
cells, we showed a decrease in F340/F380 Fura-2 signal in the
presence of TRPV4 agonist, which was rescued by wild-type
OCRL but not by the D499A mutant (Fig. 5C). Furthermore, we
isolated the Lowe syndrome patient’s keratinocytes and assayed
for their response to TRPV4 treatment. The treatment with
TRPV4 agonist failed to elicit calcium mobilization in Lowe
patient keratinocytes compared with normal keratinocytes (Fig. 5D).
The functional consequences of activating TRPV4 on eye
pressure were therefore assessed in the mouse models. The
Wistar polycystic kidney (Wpk) rat is a well-established model for
studying ciliopathy, as these animals develop hydrocephalus (41).
Previous work showed Wpk rats responded to TRPV4-targeted
treatment in hydrocephalus; we thus used these animals to test
the effect of TRPV4 agonist treatment on eye pressure. In 17-d-
oldWpk−/− rats, intraocular pressure was significantly reduced by
systemic GSK1016790A treatment but not by treatments with
a TRPV4 antagonist (HC 067047) or sham control (Fig. 5E). We
confirmed this finding in wild-type C57BL/6 mice; in animals
treated with systemic TRPV4 agonist, antagonist, or sham con-
trol, daily over 4 d, we showed a decrease in IOP from 12.4 to
10.3 mmHg (Fig. 5F). Finally, we assessed IOP in TRPV4+/+ vs.
TRPV4−/− mice. We showed that IOP in TRPV4−/− mice to be
elevated compared with control TRPV4+/+ animals (Fig. 5G).
The primary cilia in the TM of these animals were evaluated by
immunofluorescence staining for ciliary markers with Arl13b and
γ-tubulin; the cilia were found to be indeed shorter in the
TRPV4−/− mice (Fig. 5 H and I). Thus, functional OCRL is in-
dicated to be necessary for TRPV4 distribution, which in turn is
required for calcium signaling and cilia growth in response to
mechanical stimuli.
Discussion
Mechanosensation of pressure underlies a number of important
human diseases, including the development of hypertension and
glaucoma (22). Similar to the kidney, the eye is an organ with
sensitive homeostatic regulation of fluid production and outflow
(23). Defective sensation of pressure may result in imbalance of
aqueous humor, resulting in elevated intraocular pressure (28).
Low eye pressure results in structural changes of the retina and
poor vision, whereas elevated eye pressure may damage the optic
nerve (42). Here a role of primary cilia in the mechanosensation
of pressure in HTM is presented. The presence of cilia that
shortened in response to pressure in TM cells was identified by
multiple complementary approaches. Furthermore, proper
cilia function was found to be essential for pressure sensation
in these cells. These effects were found to require both OCRL
and TRPV4 in a manner where OCRL appears to be required
for proper localization and function of TRPV4 in the cilia.
This in turn is necessary for calcium flux that regulates the
Fig. 4. OCRL and TRPV4 interact and localize to the cilia. (A) OCRL coim-
munoprecipitates TRPV4. HEK293 cells transfected with FLAG-TRPV4 and
empty GFP vector, GFP-OCRL-WT, or GFP-OCRL-D499A were subjected to
immunoprecipitation with GFP-Trap_A beads. Immunoblot for GFP and
FLAG-TRPV4 was performed. Ratio of FLAG/GFP are shown as indicated. (B)
TRPV4 coimmunoprecipitates OCRL. HEK293 cells transfected with FLAG-
TRPV4 and empty GFP vector, GFP-OCRL-WT, or GFP-OCRL-D499A were
subjected to immunoprecipitation with anti-FLAG beads. Immunoblot for
GFP and FLAG-TRPV4 was performed. Ratio of OCRL/FLAG are shown as in-
dicated. (C) TRPV4 localizes with HTM cilia. HTM cells serum-starved for 48 h
were immunostained with anti-TRPV4 (green) and antiacetylated α-tubulin
(red) antibodies. DAPI in blue. (Scale bar, 5 μm.) (D) OCRL-WT but not D499A
mutant colocalize with TRPV4 in cilia. After serum-starvation for 48 h, HTM
cells transfected with FLAG-TRPV4 and GFP-OCRL-WT or GFP-OCRL-D499A
were immunostained with antiacetylated α-tubulin (red) and anti-FLAG
antibodies. OCRL and OCRL-D499A in green. FLAG-TRPV4 and DAPI in blue.
(Scale bar, 5 μm.)
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transcriptional programs that coordinate cilia function with
pressure sensing.
Once thought as a vestigial organelle, the primary cilium has
increasingly become recognized as a critical regulator of mecha-
notransduction. In the kidney epithelium, ciliary proteins poly-
cystins (PC1/2) are important for flow-dependent calcium flux
(43). In the lining of the ventricles, cerebrospinal fluid is also
regulated by cilia (18, 44). This finding is highlighted by the
ciliopathy and hydrocephalus that present in Bardet–Biedl syn-
drome 1 (BBS1) and BBS3 mutant mice (18, 44). Our study shows
that cilia in the TM cells of the eye are similarly required for the
regulation of pressure, which when dysregulated is strongly im-
plicated in the pathogenesis of glaucoma. We propose that the
mechanosensing properties of primary cilia that we have iden-
tified in TM cells are likely also in the cells within the kidneys
and the brain (Fig. 5J).
OCRL is an inositol polyphosphate 5-phosphatase that is im-
plicated in Lowe syndrome and Dent disease (1, 45, 46). The
recent discovery of its localization to cilia suggested its potential
role in the pathophysiology of glaucoma in the TM of eyes (4, 6,
7). TRPV4 has been well recognized to be a mechanosensor in
kidney epithelial cells, as well as in a number of other fluid-
regulating cell types (32, 37, 38, 40). Here we show that OCRL
interacts with TRPV4. Furthermore, we have identified a patient
with Lowe syndrome that developed congenital glaucoma at
birth, requiring filtration surgery to lower intraocular pressure.
Although TRPV4 is present in the keratinocytes isolated from
this patient, its inability to be stimulated by its agonist is strongly
suggested by our work to be a result of an enzymatic-deficient
OCRL. Based on our results, TRPV4 trafficking to the cilia is an
essential step for the release of intracellular calcium, which may
lead to subsequent enhanced Ca2+/calmodulin-dependent pro-
tein kinase II activity and up-regulate endothelial nitric oxide
synthase (47). Nitric oxide has been shown as an effector path-
way for lowering intraocular pressure (48); we propose that the
primary cilia within TM cells may serve as an afferent pathway
for signal transduction.
Interestingly, TRPV6, another TRP channel, was reported to be
suppressed by OCRL in a Xenopus model (49), suggesting that
there can be differential regulation of TRP channels by OCRL and
the PI(4,5)P2 5-phosphatase activity. Indeed, depletion of PI(4,5)P2
inactivates TRPV6 channel-mediated Ca2+ activity. However, the
role of phosphoinositides in TRP channel regulation is far from
clear as TRPV1 is negatively regulated by PI(4,5)P2, whereas hy-
drolysis of PIP2 results in activation of TRPV1 (50). Thus, future
studies are needed to distinguish the effects of OCRL on different
TRP channels in the eye as well as in other tissues.
Recently, bbs-3, which is an ADP ribosylation factor-like small
GTPase but not a component of theBBsome,was noted toplay a role
in blood pressure regulation (18). Inactivation of bbs-3 in mice
resulted in elevated blood pressure as well as hydrocephalus. Fur-
thermore, a sensory role for primary cilia was found when the PC1/2
complex stimulates the recruitment of STAT6 to promote STAT6
signaling (51). Because the loss of PC1/2 reduces the activation of
STAT6 in response to flow, the primary cilium is likely a conserved
mechanism for pressure mechanosensation across different organ
systems, including thekidney, brain, andeyes.Consistently,we show
that in response to elevated pressure, the primary cilia of TM cells
Fig. 5. OCRL and TRPV4 regulate calcium flux in HTM cells and IOP in mice. (A) Calcium flow experiment with HTM and Lowe cells. HTM or Lowe cells were
loaded with Fura-2 AM dye for 1 h, and 16 μL/s flow was applied to the cells. Representative images are shown. (Scale bar, 10 μm.) (B) Defective TRPV4-
mediated calcium signaling in HTM cells under elevated pressure. HTM cells were serum-starved (48 h) to induce ciliogenesis, followed by treatment with 0 or
50 mmHg for 3 h, Fura-2 AM dye was loaded for 1 h, followed with TRPV4 agonist GSK1016790A (0.1 μM). Ratio of F340/380 (value × 1000) that indicates
calcium mobilization is shown, with average from three independent experiments. Error bars represent SD, paired t test, *P < 0.001. (C) OCRL is required for
TRPV4-mediated calcium signaling in HTM cells. HTM cells were treated with OCRL siRNA or scrambled control siRNA, with or without wild-type OCRL or
OCRL-D499A rescue. TRPV4 agonist GSK1016790A (0.1 μM) treatment was performed and calcium mobilization by F340/380 (value × 1000) was measured and
shown. n > 50 cells, Representative of three independent experiments, error bars represent SD. paired t test, *P < 0.001. (D) Lowe syndrome patient cells
exhibit defective TRPV4-mediated calcium flux. NHKC or Lowe keratinocytes were serum-starved, loaded with Fura-2 AM and then treated with TRPV4
agonist; F340/380 ratio (value × 1000) was determined. Average of three independent experiments, error bars represent SD, paired t test, *P < 0.001. (E)
TRPV4 agonist but not antagonist lowers IOP in a rat model. Eight-d-old wpk−/− rats were treated with sham, TRPV4 agonist (GSK 1016790A, 20 ng·mL·d), or
antagonist (HC 067047, 50 ng·mg·d) for 8 d. At day 17, IOP measurements (mmHg) were performed using a Tonolab tonometer. Error bars represent SD. n = 4,
unpaired t test, *P < 0.05. (F) TRPV4 agonist but not an antagonist lowers IOP in mouse. Nine-week-old C57BL/6 WT mice were treated with sham, TRPV4
agonist GSK 1016790A or antagonist HC 067047 for 4 d. IOP was measured using a Tonolab tonometer 24 h after treatment. Error bars represent SD. n = 20,
three independent experiments, unpaired t test, *P < 0.01. (G) TRPV4−/− mice exhibited higher IOP than TRPV4+/+ mice. IOP measurements of 7-mo-old
TRPV4+/+ (n = 4) and TRPV4−/− (n = 6) were determined. Error bars represent SD, paired t test, *P < 0.05. (H and I) Shortened cilia in TM cells of TRPV4−/−.
Primary cilia in paraffin-embedded sections from both TRPV4+/+ and TRPV4−/−mouse eyes were stained with acetylated α-tubulin (n = 5 per group, total of 50
cilia per group were measured). Quantification of cilia length (H) and representative images (I) are shown. Error bars represent SD, paired t test, *P < 0.05.
(Scale bar, 5 μm.) (J) Model for OCRL and TRPV4 function in the cilia in TM cells.











are shortened in both in vitro culture and mammalian eyes. The
identification of primary cilia in the TM, and the central role of
OCRL and TRPV4 in their function, begins to define our un-
derstanding of aqueous regulation and therefore points to novel
targets for glaucoma therapy.
Materials and Methods
TRPV4 agonist (GSK 1016790A) and antagonist (HC 067047) were obtained
from Sigma and TOCRIS, respectively. Cycloheximide was obtained from Sigma
(C7698). Antiacetylated α-tubulin, anti–β-actin, and anti–γ-tubulin monoclonal
antibodies were purchased from Sigma. For more details, see SI Materials and
Methods and Table S1.
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